Paulomi Barman is a journalist based in Tokyo Prefecture, Japan.
She has been working for the Indian News Media for the past 4 years and has recently shifted to Tokyo ( 2019 ). During her work experience in India, she has worked with emminent journalists like Rajdeep Sardesai, Rahul Kanwal, ...

COVAXIN Shows Better Antibody Response In Children Aged Between 2-18 Years Than Adults

01 Oct 2023  |  THE NEW INDIAN  |  English  |  Health

Bharat Biotech International Limited confirms that COVAXIN has shown better antibody response in children aged 2-18 years compared to adults, following successful phase II/III trials. The trials, conducted on 525 children, reported no serious adverse effects and demonstrated the vaccine's safety and immunogenicity. The data, submitted to the Central Drugs Standard Control Organisation, led to emergency use approval for children aged 12-18 years. Bharat Biotech aims to reach an annualized production capacity of 1 billion doses by the end of 2021, with technology transfer activities underway in India, the United States, and other countries.

Tags:

Bharat Biotech

Factual

Factuality Scale

I am an experienced freelance writer and editor. I am the autor of "Cura Espiritual: Uma Investigação", a book about spiritual healing, and "Chico Xavier", a biography about the medium Chico Xavier, the most famous religious personality in Brazil. My best work is on science and health. But I´ve ...

We Knocked on the Door of the Company That Requested an Advance for Covaxin

25 Jun 2021  |  www.intercept.com.br  |  Portuguese  |  Corruption

A political crisis has emerged in Brazil involving the government of Jair Bolsonaro and the company Madison Biotech, which allegedly requested an advance payment of $45 million for the Indian vaccine Covaxin. The whistleblowers, Luis Miranda and his brother Luis Ricardo Miranda, reported the issue to Bolsonaro, who promised to forward it to the Federal Police but did not. The Senate's Pandemic CPI suspects Madison Biotech is a shell company used for irregular transactions. The investigation revealed that Madison Biotech's registered address in Singapore is merely a fiscal address, with no actual operations. Bharat Biotech, the manufacturer of Covaxin, is linked to Madison Biotech. The article raises concerns about potential corruption and the government's handling of the situation.

Tags:

Bharat Biotech Madison Biotech

Interpretive

Factuality Scale

Center-Left

Political View

Gautam Doshi is a multimedia journalist and a documentary photographer based in Mumbai who is interested in human rights, climate change, environmental issues, development and systemic barriers, and rights for people with disabilities.

In August 2019, Gautam received the Bob & Diane Fund (by Ms. ...

Electoral bonds linked to project clearances by BRS government in Telangana

05 Oct 2023  |  www.thehindu.com  |  English  |  Corruption

The Bharat Rashtra Samithi (BRS) in Telangana is alleged to have linked the purchase of electoral bonds to the award of contracts and project clearances. Companies like IRB Infra and Kitex Garments made significant bond purchases shortly after receiving government contracts, raising suspicions of corruption. The State Bank of India disclosed details of electoral bond purchases following a Supreme Court directive, revealing that various companies across industries donated to multiple political parties, with the BRS being a major recipient. The article highlights the potential misuse of electoral bonds for political funding, implicating several companies and political parties.

Tags:

Bharat Biotech IRB Infra Kitex Garments Dr. Reddy’s Laboratories Natco Pharma Aurobindo Pharma Granules Chiron Behring Vaccines Cyient NCC MSN Hetero Hazelo Labs Hindys Labs Welspun Living BSCPL Infrastructure Tellapur Technocity KNR Constructions Tsharks Infra Developers Tsharks Overseas Education NSL SEZ Hyderabad Inorbit Malls Sagar Cements Rithwik Projects Mytrah Greenko ITC Raheja Rajpushpa Yashoda Hospitals

Interpretive

Factuality Scale

Center-Left

Political View

Vijitra Duangdee is a journalist based in Bangkok, Thailand.

Coronavirus vaccine race: how many doses have Asia-Pacific countries ordered?

28 Dec 2020  |  South China Morning Post  |  English  |  Current Affairs

Asia-Pacific countries have secured various amounts of COVID-19 vaccine doses from different suppliers, with plans to begin vaccinations between February and March 2021. Japan, South Korea, Australia, the Philippines, Indonesia, Vietnam, Thailand, Singapore, Myanmar, Malaysia, Cambodia, Laos, and Brunei have all made arrangements for vaccine procurement, with some countries also developing their own vaccines. The vaccines mentioned include those from Pfizer-BioNTech, Oxford-AstraZeneca, Moderna, Novavax, Johnson & Johnson, Sinovac, Sinopharm, CanSino Biologics, and local developers such as Bharat Biotech International Limited and Nanogen Biopharmaceutical Biotechnology. The WHO-backed Covax Facility is also mentioned as a source for vaccine doses.

Tags:

Nanogen Biopharmaceutical Biotechnology Bharat Biotech International Limited Pfizer-BioNTech Oxford-AstraZeneca Moderna Novavax Johnson & Johnson Shionogi & Co Sinovac Sinopharm CanSino Biologics

Factual

Factuality Scale

Lobato Felizola is a Brazilian journalist.

Covid-19 Vaccine Scandal Could Be the Final Straw for Bolsonaro Supporters

21 Mar 2024  |  nacla.org  |  English  |  Corruption

Brazil's handling of the pandemic, particularly the procurement of Covid-19 vaccines, has come under scrutiny with allegations of corruption and negligence within the Health Ministry. A parliamentary inquiry commission (CPI) has been investigating the government's response, uncovering evidence of overpricing and irregularities in the contract for the Indian Covaxin vaccine. President Jair Bolsonaro, who campaigned on anti-corruption, is implicated in the scandal, having been informed of the irregularities but failing to act. The scandal has led to protests, weakened Bolsonaro's anti-corruption stance, and may impact his chances in the 2022 elections. Despite this, Bolsonaro still has a strong following on social networks, which could influence his re-election campaign.

Tags:

Bharat Biotech Pfizer-BioNTech

Informative

Factuality Scale

Center

Political View

Prakash Kumar is a journalist based in New Delhi, with two decades of experience in the profession. He has worked with the Hindustan Times, Press Trust of India (PTI), Deccan Herald and some other publications in India. In 20 years of journalism, he has covered a rage of areas from crime, extremism,...

32 Vials Of Covaxin Stolen From Jaipur Hospital Amid Vaccine Shortage In Rajasthan

04 Oct 2023  |  https://www.outlookindia.com/  |  English  |  COVID-19

A batch of 32 vials, equivalent to 320 doses, of Bharat Biotech’s Covaxin was stolen from Jaipur’s Kanwatiya Hospital in Shastri Nagar. The theft occurred during transit to cold storage, prompting the hospital to immediately inform the police. This incident comes amid a vaccine shortage in Rajasthan.

Tags:

Bharat Biotech

Informative

Factuality Scale

Professional Experience:  

Working  in Sai Media and Advertising Services 
&  Associated with International Media for  providing News & Contents.  - Working since Jan.2016 to till this date in Jharkhand.
Associated with short film making,research 
Worked with  [ Freelancer ]  LionBridge  ...

India begins ‘world’s biggest’ vaccination drive

16 Jan 2021  |  www.arabnews.pk  |  English  |  Politics

India launched a massive vaccination campaign against the coronavirus, targeting 30 million front-line health workers and 270 million high-risk individuals. Two locally produced vaccines, Covishield and Covaxin, are being used. Prime Minister Narendra Modi praised Indian scientists for developing the vaccines rapidly. Some healthcare workers have been vaccinated, while others express concerns over Covaxin's efficacy due to incomplete trials. The Indian Medical Association endorses both vaccines, but calls for more transparency and data are prevalent.

Tags:

Bharat Biotech Serum Institute of India

Informative

Factuality Scale

I am a documentary filmmaker, photographer, multimedia journalist and conservation storyteller currently based and registered for business in Suva, Fiji. I specialise in impactful storytelling related to social justice, human rights, climate change, climate resilience, environmental conservation, ...

FDA Approves First Chikungunya Vaccine as Global Cases Rise

10 Nov 2023  |  Hindustan Times  |  English  |  Science & Environment

The US FDA has approved the first chikungunya vaccine developed by Valneva Austria GmbH for adults at risk of exposure. The vaccine is a live attenuated virus administered in a single dose and has been tested in North America with common mild side effects. Chikungunya is a mosquito-borne virus causing severe joint pain and has affected over 110 countries. The Aedes aegypti and Aedes albopictus mosquitoes spread the virus, which has seen a global increase in cases partly due to viral adaptations and climate change. India has experienced a significant number of chikungunya cases, with a recent rise in suspected and confirmed cases. The approval of Valneva's vaccine is a positive step, and Bharat Biotech in India is also developing a vaccine. Anirban Mahapatra, a scientist and author, provides his personal views on the matter.

Tags:

Bharat Biotech Valneva Austria GmbH

Lluis Muñoz Pandiella is a journalist based in Barcelona, Spain.

Thousands protest in Brazil against Bolsonaro for his handling of the pandemic

04 Jul 2021  |  www.france24.com  |  Spanish  |  Corruption

In Brazil, thousands protested against President Jair Bolsonaro's handling of the pandemic, with over 523,000 deaths recorded and slow vaccination progress. The protests, initially scheduled for later in July, were intensified by corruption allegations involving vaccine procurement. The Supreme Court authorized a 90-day investigation into Bolsonaro's involvement in a $316 million contract for the Indian vaccine Covaxin. Additionally, a police officer confessed to attempting to sell 400 million doses of AstraZeneca vaccines to the government, which was halted due to corruption. Bolsonaro's approval has significantly dropped, with former President Lula da Silva leading in polls for the 2022 elections.

Tags:

Bharat Biotech AstraZeneca

Interpretive

Factuality Scale

Left

Political View

I  am  a journalist based in Srinagar. I  have worked for over 12 years to cover the Kashmir conflict including major political developments as well as gunfights. I have also done business reporting in different parts of India while working for one of India's largest newspapers, Indian Express.

COVID-19 vaccine shortages hit Kashmir Valley but inoculation drive on track in BJP-dominated plains

17 May 2021  |  www.firstpost.com  |  English  |  Regional Disparities

COVID-19 vaccine shortages are significantly affecting the Kashmir Valley, with most districts halting inoculation efforts. In contrast, the Jammu region, a BJP stronghold, has nearly completed vaccinations for people up to 45 years of age. The disparity in vaccine distribution has led to criticism from local leaders and health officials, who highlight the urgent need for equitable vaccine allocation. The Central government has shifted the responsibility of vaccine procurement to local authorities, exacerbating the shortages in Kashmir. The ongoing lockdown and enforcement measures aim to curb the spread of the virus amid the vaccination delays.

Tags:

Bharat Biotech Serum Institute of India

Interpretive

Factuality Scale

Center-Left

Political View

I am a journalist based in São Paulo (SP), Brasil. I have worked for Folha de S.Paulo, Brazil's largest newspaper, covering education, culture and other subjects.

Complaints about vaccine targeted by Covid CPI are stalled in Justice

06 Dec 2023  |  noticias.uol.com.br  |  Portuguese  |  COVID-19 Vaccine Scandal

Federal Public Ministry allegations against those responsible for selling the Indian vaccine Covaxin to the Brazilian government, which was targeted by the Covid CPI, have been stalled for over a year in the judiciary. On June 24, 2022, Judge Maria do Carmo of the Federal Regional Court of the 1st Region suspended a case before the court could decide whether to accept the indictment of 11 people for ideological falsehood and embezzlement during the vaccine negotiation. The case's progress is halted as the court has yet to decide on the merits of an appeal questioning whether the Supreme Federal Court should have jurisdiction due to the involvement of Congressman Ricardo Barros, who has privileged jurisdiction. The Public Ministry accused Precisa's members, including owner Francisco Emerson Maximiano, of using false documents to represent themselves as representatives of the Indian laboratory Bharat Biotech, which produced Covaxin. Additionally, Precisa executives were charged with embezzlement for presenting a false bank guarantee letter issued by FIB Bank. FIB Bank's president, Roberto Ramos Júnior, and Marcos Tolentino, considered a hidden partner of the company, were also accused of ideological falsehood. Another case involving some of the same individuals has been similarly suspended by the TRF-1 since October 2021, concerning a Federal Police investigation into fraud in high-cost medicines involving Global Saúde, another company of Francisco Emerson Maximiano. Congressman Ricardo Barros denies any connection to the inquiries, stating that the alleged link is cited by lawyers as a legal strategy to buy time. The lawyers for Francisco Maximiano claim that the judicial decisions met defense requests due to a clear conflict of jurisdiction and privileged forum.

Tags:

Bharat Biotech Precisa FIB Bank Global Saúde

Informative

Factuality Scale

Neutral

Political View

Shaifal Sayyed is a talented digital marketer and freelance journalist hailing from Mumbai, India. His journalistic journey began during the first wave of the COVID-19 pandemic in India, where he ventured into the heart of ground stories and covered a myriad of compelling events during the lockdown....

India approves Johnson & Johnson Covid vaccine for emergency use

17 Mar 2024  |  independentjournalist2021.blogspot.com  |  English  |  COVID-19 Vaccine Approval

India's health minister, Mansukh Mandaviya, announced that the country has granted emergency use authorization to Johnson & Johnson's single-dose Covid-19 vaccine. Johnson & Johnson had previously applied for the approval and plans to bring the vaccine to India through a supply agreement with Biological E Ltd, a domestic vaccine manufacturer. India has already approved Covid-19 vaccines from AstraZeneca, Bharat Biotech, Russia's Gamaleya Institute, and Moderna for emergency use.

Tags:

Bharat Biotech Johnson & Johnson Biological E Ltd AstraZeneca Moderna

Akanki Sharma is a journalist.

'One quality, one standard': Bharat Biotech chairman calls for FDA merger

06 Feb 2023  |  www.theweek.in  |  English  |  Regulation

Bharat Biotech chairman Dr Krishna Ella advocates for merging state and central Food and Drug Administrations in India to ensure uniform quality standards amid criticism over drug manufacturing lapses. He emphasizes the need for a centralized regulatory system and highlights the political nature of the decision. The call comes as India faces scrutiny over drug-related deaths abroad. Dr Ella also discusses Bharat Biotech's preparedness for future health crises and ongoing vaccine development. The article also covers the partnership between the Ella Foundation and the University of Wisconsin-Madison Global Health Institute to establish a health center in Bengaluru, aimed at advancing vaccine research and development.

Tags:

Bharat Biotech

Balanced

Factuality Scale

Subhash Sharma is a award winning  journalist / Photojournalist / Video Journalist / DOP  based in Mumbai, India. Available for assignments all over India within a short notice.

His work has been featured in various publications like  TIME magazine USA, Nikkei Japan, Venerdi Italy, The Globe and ...

The pandemic accelerates in India, with a record number of covid deaths

29 Apr 2021  |  www.infobae.com  |  Spanish  |  Vaccination Campaign

India's COVID-19 situation is worsening with a new daily death record, surpassing 200,000 fatalities. The country faces vaccine shortages and political disputes over distribution. Despite producing millions of doses monthly, India's vaccination campaign is struggling. The Serum Institute of India and Bharat Biotech are ramping up production, but states like Maharashtra and New Delhi report shortages. The Pan American Health Organization calls for more vaccines in Latin America, where the situation is critical. Vaccine manufacturers like Moderna and BioNTech are preparing for future needs, including potential booster shots. International aid is arriving in India as the country battles a surge in cases and variant concerns.

Tags:

Sinovac Biotech Bharat Biotech Serum Institute of India AstraZeneca Johnson & Johnson Moderna BioNTech Pfizer

Informative

Factuality Scale

Far Left

Political View

Jyoti Shelar is a journalist.

Oxygen shortage in India’s Maharashtra as COVID cases soar

17 Apr 2021  |  www.aljazeera.com  |  English  |  Oxygen Shortage

Maharashtra, India's wealthiest state, is facing a severe oxygen shortage amid a surge in COVID-19 cases. Patients are struggling to find hospital beds and oxygen support, with the state's oxygen usage exceeding its production. The Chief Minister has requested the Prime Minister to deploy the National Disaster Management Authority for airlifting oxygen. Nandurbar district is opening a modified train with 336 beds as an isolation center. The state has imposed new restrictions to curb infections, and Mumbai is using innovative methods to improve bed availability. Despite leading in vaccinations, Maharashtra faces a vaccine shortage, highlighting the need for stronger vaccination efforts and containment measures.

Tags:

Bharat Biotech Serum Institute of India

Factual

Factuality Scale